EPRX
Eupraxia Pharmaceuticals
$7.38
+$0.30 (+4.24%)Oct 28, 2026
Key metrics
The numbers that frame EPRX today
- Market cap
- $483.20M
- ROIC
- -123.8%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $5.25
- 52wk High
- $9.32
Growth
Revenue and earnings trend for EPRX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about EPRX
Is Eupraxia Pharmaceuticals a good buy?
Hold. Eupraxia Pharmaceuticals has excellent momentum, but poor quality makes the setup mixed. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Eupraxia Pharmaceuticals is selling at a very high price.
What is the market capitalization of EPRX?
Eupraxia Pharmaceuticals's market capitalization is $483.20M.
What is the 52-week high for EPRX stock?
The 52-week high for Eupraxia Pharmaceuticals is $9.32. The current close of $7.38 is 20.8% below that high.
What is the 52-week low for EPRX stock?
The 52-week low for Eupraxia Pharmaceuticals is $5.25. The current close of $7.38 is 40.6% above that low.
Does EPRX stock pay dividends?
Eupraxia Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for EPRX?
Eupraxia Pharmaceuticals's Debt / Equity ratio is 0.01.